全文获取类型
收费全文 | 2139篇 |
免费 | 128篇 |
国内免费 | 82篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 119篇 |
妇产科学 | 27篇 |
基础医学 | 280篇 |
口腔科学 | 41篇 |
临床医学 | 328篇 |
内科学 | 518篇 |
皮肤病学 | 33篇 |
神经病学 | 107篇 |
特种医学 | 304篇 |
外科学 | 254篇 |
综合类 | 30篇 |
预防医学 | 56篇 |
眼科学 | 16篇 |
药学 | 102篇 |
肿瘤学 | 131篇 |
出版年
2021年 | 12篇 |
2019年 | 19篇 |
2018年 | 17篇 |
2017年 | 13篇 |
2016年 | 17篇 |
2015年 | 23篇 |
2014年 | 27篇 |
2013年 | 43篇 |
2012年 | 30篇 |
2011年 | 41篇 |
2010年 | 63篇 |
2009年 | 59篇 |
2008年 | 58篇 |
2007年 | 99篇 |
2006年 | 55篇 |
2005年 | 61篇 |
2004年 | 56篇 |
2003年 | 48篇 |
2002年 | 51篇 |
2001年 | 57篇 |
2000年 | 60篇 |
1999年 | 57篇 |
1998年 | 103篇 |
1997年 | 98篇 |
1996年 | 125篇 |
1995年 | 95篇 |
1994年 | 99篇 |
1993年 | 86篇 |
1992年 | 54篇 |
1991年 | 50篇 |
1990年 | 49篇 |
1989年 | 58篇 |
1988年 | 54篇 |
1987年 | 44篇 |
1986年 | 52篇 |
1985年 | 49篇 |
1984年 | 24篇 |
1983年 | 35篇 |
1982年 | 35篇 |
1981年 | 42篇 |
1980年 | 24篇 |
1979年 | 18篇 |
1978年 | 20篇 |
1977年 | 22篇 |
1976年 | 20篇 |
1975年 | 16篇 |
1974年 | 14篇 |
1973年 | 12篇 |
1969年 | 9篇 |
1968年 | 17篇 |
排序方式: 共有2349条查询结果,搜索用时 15 毫秒
1.
M A Warner K H Neill J V Nadler B J Crain 《Journal of cerebral blood flow and metabolism》1991,11(4):600-610
This study compared the ability of three N-methyl-D-aspartate (NMDA) receptor antagonists to prevent neuronal degeneration in an animal model of global cerebral ischemia. The model employed is characterized by damage to the striatum, hippocampus, and neocortex. Antagonists were administered to gerbils either before or after a 5-min bilateral carotid occlusion. The intraischemic rectal temperature was either maintained at 36-37 degrees C or allowed to fall passively to 28-32 degrees C. Antagonists and doses tested were 1 and 10 mg/kg of MK-801 (pre- or postischemia), 30 mg/kg of CGS 19755 preischemia, four 25 mg/kg doses of CGS 19755 administered between 0.5 and 6.5 h postischemia, and 40 mg/kg of MDL 27,266 (pre- or postischemia). All three NMDA receptor antagonists exhibited some degree of neuroprotective activity when the carotid occlusion was performed under normothermic conditions. Most of the treatments with antagonist markedly reduced striatal damage. CA1 hippocampal and neocortical pyramidal cells were spared by only three of the treatments, however, and the extent of neuroprotection varied widely from case to case. Toxic doses of antagonist were required to protect CA1 pyramidal cells from ischemic damage. Ischemic damage to hippocampal areas CA2-CA3a and CA4 appeared to be resistant to all of these treatments. Most CA1 pyramidal cells that were protected from degeneration by an NMDA receptor antagonist were histologically abnormal. The neuroprotective effects of MK-801 and intraischemic hypothermia appeared to be additive. MK-801 (10 mg/kg) consistently reduced the postischemic brain temperature, but only the magnitude of hypothermia produced soon after reperfusion correlated with its neuroprotective action. These results suggest that NMDA receptor antagonists are relatively poor neuroprotective agents against a moderately severe ischemic insult. 相似文献
2.
3.
4.
5.
External beam radiation therapy (EBRT) and brachytherapy are common treatment modalities for newly diagnosed prostate cancer. What complications can patients and physicians expect following these therapies? How are these conditions diagnosed and treated? In this article, we examine several of the most common acute and delayed complications of radiation therapy for prostate cancer. In addition, we discuss appropriate follow-up diagnostics for these patients and our suggestions for management of the main complications that may develop. 相似文献
6.
7.
8.
9.
10.
Y Leskinen JP Salenius T Lehtim?ki H Huhtala H Saha 《American journal of kidney diseases》2002,40(3):472-479
BACKGROUND: Knowledge of the prevalence of peripheral arterial disease (PAD) in patients with chronic renal failure (CRF) is limited because of a lack of uniformity in disease definition and recognition. Furthermore, little is known of the prevalence of medial arterial calcification (MAC) in patients with CRF. Our goal is to study the prevalence of PAD and MAC defined by ankle brachial index (ABI) or toe brachial index (TBI) measurements in a Finnish population of patients with CRF consisting of predialysis and dialysis patients, as well as renal transplant recipients. METHODS: We examined 136 patients with CRF and 59 control subjects. Fifty-nine of the patients with CRF had moderate to severe predialysis CRF, 36 patients were on dialysis treatment, and 41 were renal transplant recipients. Mean age of patients was 51.9 +/- 11.5 years, and 39 patients (29%) had diabetes. ABI and TBI were measured by means of photoplethysmography. The definition of PAD required an ABI value of 0.90 or less, a TBI value of 0.60 or less, or a previous positive lower-extremity angiogram result. ABI values of 1.3 or greater or incompressible arteries at ankle level indicated MAC. The presence of claudication was determined by an interview. RESULTS: Prevalences of PAD on this study were 22.0% in patients with predialysis CRF, 30.6% in patients on dialysis treatment, 14.6% in renal transplant recipients, and 1.7% in the control group (P = 0.001). Prevalences of MAC were 23.7%, 41.7%, 23.1%, and 3.4% (P < 0.001), respectively. Only 9 patients had claudication, and 6 of those patients had PAD. CONCLUSION: Both asymptomatic PAD and MAC are common in patients with CRF. Therefore, we recommend the use of both ABI and TBI measurements in the evaluation of PAD in patients with CRF. 相似文献